Rella W, Winterleitner H, Knapp W
Blut. 1979 Jul;39(1):17-25. doi: 10.1007/BF01008071.
The MLC-activating potential of 25 ALL blasts (16 "common" ALL, 6 T-ALL, 3 not identified) was investigated. Mitomycin-treated leukemic blasts or X-irradiated lymphocytes were cultured with heparinized whole blood from different healthy donors. MLC activation by blast cells was expressed as percentage of MLC activation by X-irradiated lymphocytes. Leukemic blasts showed a heterogeneous pattern of MLC activation, ranging from 2% to 245%. Eleven out of 25 cases of ALL poorly stimulated the MLC (2% to 33% response). Twelve ALL stimulated a normal response (50% to 120%); and 2/25 ALL stimulated a supranormal response (more than 200%). Four of six cases of T-ALL stimulated the MLC as efficiently as irradiated lymphocytes, 2/6 were among the poor stimulators. Most poor stimulator blasts had, however, normal MLC-activating properties if, instead of whole blood, isolated lymphocytes were used as the responding cells. The poor activation of lymphocytes by some leukemic blasts in whole blood appeared to be associated with impaired release of blastogenic factor(s) during the MLBC. No evidence for active suppressor mechanisms was found. The significance of the MLC-activating properties of leukemic blasts for the classification and immunotherapeutic use of ALL is discussed.
研究了25例急性淋巴细胞白血病(ALL)原始细胞(16例“普通”ALL、6例T-ALL、3例未分型)的混合淋巴细胞培养(MLC)激活潜能。将丝裂霉素处理的白血病原始细胞或经X射线照射的淋巴细胞与来自不同健康供体的肝素化全血一起培养。原始细胞引起的MLC激活以经X射线照射的淋巴细胞引起的MLC激活的百分比表示。白血病原始细胞表现出异质性的MLC激活模式,范围为2%至245%。25例ALL中有11例对MLC刺激较弱(反应率为2%至33%)。12例ALL刺激产生正常反应(50%至120%);25例ALL中有2例刺激产生超常反应(超过200%)。6例T-ALL中有4例刺激MLC的效率与照射淋巴细胞相同,6例中有2例属于弱刺激者。然而,如果使用分离的淋巴细胞而非全血作为反应细胞,大多数弱刺激原始细胞具有正常的MLC激活特性。某些白血病原始细胞在全血中对淋巴细胞的弱激活似乎与混合淋巴细胞培养反应(MLBC)期间促有丝分裂因子释放受损有关。未发现活性抑制机制的证据。讨论了白血病原始细胞的MLC激活特性对ALL分类和免疫治疗应用的意义。